COPD and Asthma Devices Market to Reach $41,355.2 Million, Globally, by 2022 with key players GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc., AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products, Inc., Sunovion Pharmaceutic

Global COPD and asthma devices market is expected to reach $41,355.2 million by 2022, according to a new report by Allied Market Research . The drug powder inhaler was the highest revenue-generating segment, accounting for over half of the share in 2015. This segment is expected to maintain its dominance throughout the forecast period.

The factors hampering the market growth include environmental concerns associated with metered dose inhalers (MDI) and high cost of selected inhalation devices. Regulatory authorities such as U.S. food and drug administration (USFDA) across several regions have banned the production and sales of MDIs, as they release environmentally hazardous gases such as chlorofluorocarbon (CFC) and hydrofluoroalkanes (HFA). Thus, soft mist inhalers (SMIs) and nebulizers are expected to replace MDIs for the treatment of respiratory diseases in the near future.

Get sample copy of this report at:
https://www.alliedmarketresearch.com/request-sample/579

Key findings of COPD and Asthma Devices Market:

• Drug powder inhalers (DPIs) segment is projected to grow at a significant CAGR of 5.7% during the forecast period.

• North America was the leading region in 2015, and is expected to continue its dominance throughout the analysis period.

• The COPD and asthma devices market in Europe is projected to grow at a CAGR of 6.1%.

• The compressor nebulizers segment is expected to register a CAGR of 5.4%.

North America is expected to remain the highest revenue-generating region, owing to widespread and early adoption of inhalers & nebulizers and large pool of patients suffering from respiratory diseases. Moreover, the Asia-Pacific region is expected to grow rapidly due to rising healthcare expenditure, growing awareness of advanced portable COPD & asthma devices, and increasing disposable income.

Get customized copy of this report at:
https://www.alliedmarketresearch.com/request-for-customization/579

Key players:

• GlaxoSmithKline Plc
• Novartis AG
• Merck & Co.Inc.
• AstraZeneca Plc
• Philips Healthcare
• 3M Health Care
• Allied Healthcare ProductsInc.
• Sunovion Pharmaceuticals Inc.
• GF Healthcare Products
• Smith Medicals Inc.
• Lincare Holdings Inc.
• Baxter International.

Table of content:


Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Primary research
1.4.2 Secondary Research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond what to expect by 2027

2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top impacting factors
3.2.2 Top investment pockets
3.2.3 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of buyers (High)
3.3.2 Bargaining power of suppliers (Low to Moderate)
3.3.3 Threat of new entrants (Low)
3.3.4 Threat of substitutes (High)
3.3.5 Intense competitive rivalry

3.4 Value chain analysis
3.5 Market share analysis, 2015
3.6 Government regulations

3.6.1 COPD devices regulations in Europe and in the U.S.
3.6.2 COPD devices regulations in Asia-Pacific

3.7 Drivers

3.7.1 Daily exposure to environmental pollution
3.7.2 Increase in population susceptible to indoor air pollutants
3.7.3 Portability of the drug delivery devices
3.7.4 Increasing population of Active smokers
3.7.5 Rising government initiatives

3.8 Restraints

3.8.1 Increasing price competition and deterioration of material quality
3.8.2 Overall high cost of asthma treatment is a challenge for the patients
3.8.3 Incompetent reimbursement support

3.9 Opportunities

3.9.1 Patent expiration for blockbuster drugs
3.9.2 Soft Mist Inhalers (SMIs): future growth driver

Access full summary if this report at:
https://www.alliedmarketresearch.com/COPD-asthma-devices-market

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Sona Padman
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.